Published in Women's Health Weekly, October 11th, 2001
The new research adds evidence to a growing belief that gene therapies preventing angiogenesis in targeted tissues could be used for treating a number of human diseases. Angiostatin, a protein obtained during plasminogen activity, is just one of a few angiogenesis inhibitors that scientists are investigating for their usefulness in curbing angiogenic processes.
"In this study, we have expressed the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.